EPIEN Medical is focused on addressing the global health challenges of restoring impaired tissue layers of the oral mucosa and submucosa. This is accomplished through a groundbreaking debridement technology based around a proprietary chemical desiccation process.


EPIEN Medical’s proprietary debridement process is Desiccation Shock Debridement (“DSD”) Technology and is a novel breakthrough for treating epidermal and dermal tissue injuries.


Our company’s legacy is a deep commitment to develop innovative and patented product platforms for nonbiologic, therapeutic treatments to restore and regenerate impaired epidermal and dermal tissue.

“In my opinion, Epien Medical provides the most rapidly effective anti-biofilm, wound bed preparation modality, regardless of wound etiology. For me, it has become integral to the practice of effective wound care.”

– Marcus Gitterle MD, FACCWS